Candida lusitaniae

Candida lusitaniae Overview

Candida lusitaniae is an uncommon cause of infection, but it is noteworthy for its ability to rapidly develop resistance to amphotericin B. It has been reported to cause opportunistic infections, including catheter-related and wound infections, particularly in immunocompromised patients. Including C. lusitaniae in a wound or women’s health PCR panel ensures that this rare but clinically significant yeast is identified and appropriate antifungal treatment is selected (Apsemidou et al. 2020, Krcmeryet al.  2002).

References

Apsemidou, A., Füller, M. A., Idelevich, E. A., Kurzai, O., Tragiannidis, A., & Groll, A. H. (2020). Candida lusitaniae Breakthrough Fungemia in an Immuno-Compromised Adolescent: Case Report and Review of the Literature. Journal of fungi (Basel, Switzerland)6(4), 380.

Krcmery, V., & Barnes, A. J. (2002). Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance. The Journal of hospital infection50(4), 243–260.

Products used to detect Candida lusitaniae

The women’s health large PCR panel is designed for multiplex in vitro assessment of 37 common vaginal microbiota and resistance markers, using real-time PCR.
The wound large PCR panel is designed for multiplex in-vitro assessment of 30 microbiota associated with wounds or tissue damage, using real-time PCR.